Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta [Phase 4]
A Phase 4 study completed to assess if restarting interferon-beta therapy after a washout period is beneficial for relapsing-remitting multi…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS [Phase 4]
A Phase 4 trial evaluating Avonex (Interferon-beta-1a) with or without methylprednisolone for relapsing-remitting multiple sclerosis has com…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
This post-authorization observational study reports on cognition and fatigue in relapsing-remitting multiple sclerosis patients treated with…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Efficacy of Fish Oil in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial results evaluate the efficacy of fish oil as an adjunct in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities
A completed clinical trial evaluating glatiramer acetate in relapsing-remitting multiple sclerosis, including participants with autoimmune c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
This entry reports the completion of a longitudinal clinical trial evaluating the effects of Copaxone (glatiramer acetate) in relapsing-remi…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Rehabilitation Study in MS Patients [Phase 4]
A Phase 4 rehabilitation study in relapsing-remitting multiple sclerosis sponsored by Bayer was terminated. Results from the terminated tria…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Study Evaluating CCI-779 in Relapsing Multiple Sclerosis [Phase 2]
Phase 2 study evaluating CCI-779 (temsirolimus) in relapsing multiple sclerosis has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Treatment Interruption of Natalizumab [Phase 2]
A Phase 2 trial evaluating interruption of natalizumab therapy in relapsing-remitting multiple sclerosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients [Phase 2]
Phase 2 dose-finding study of ofatumumab in relapsing-remitting multiple sclerosis completed; results were posted.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] [Phase 2]
A Phase 2 study tested adding minocycline to Interferon beta-1a (Rebif) in relapsing-remitting multiple sclerosis; the trial was terminated …
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient [Phase 4]
Update on a Phase 4 clinical trial evaluating the effects of Vitamin A on gene expression in patients with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]
This report presents long-term efficacy and safety data for fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis from…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine [Phase 2]
A Phase 2 safety and efficacy study evaluates Copaxone (glatiramer acetate) administered with N-acetylcysteine for Relapsing-Remitting Multi…
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients [Phase 4]
Phase 4 clinical trial evaluating emotional disorders in relapsing-remitting multiple sclerosis patients treated with interferon beta; resul…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Sensori-motor Integration Training in Multiple Sclerosis [EARLY_Phase 1]
This update notes the completion of an early-phase 1 trial evaluating sensori-motor integration training for relapsing-remitting multiple sc…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
A completed clinical trial update detailing pharmacokinetic, immunological, and biochemical sample collection and analysis in a natalizumab-…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b [Phase 2]
Phase 2 trial evaluating the efficacy, safety and tolerability of atorvastatin 40 mg in patients with relapsing-remitting multiple sclerosis…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
A completed trial evaluating the safety and effectiveness of adding monthly dexamethasone to weekly Avonex in people with relapsing-remittin…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone [Phase 4]
Phase IV study evaluating Rebif (interferon beta-1a) 44 mcg given subcutaneously three times weekly versus no treatment after mitoxantrone i…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Safety of New Formulation of Glatiramer Acetate [Phase 3]
A Phase 3 trial assessing the safety of a new formulation of glatiramer acetate in relapsing-remitting multiple sclerosis has completed with…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. [Phase 2]
A Phase 2 study evaluated the safety and effectiveness of Novantrone therapy followed by Copaxone in Relapsing-Remitting Multiple Sclerosis.…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline [Phase 2]
Phase 2 safety and efficacy study evaluating Copaxone in combination with minocycline for relapsing-remitting multiple sclerosis; the trial …
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod [Phase 2]
Phase 2 trial evaluating the effectiveness, tolerability and safety of laquinimod for relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
A clinical trial update reports on how titration, analgesics, and BET A nurse support influence acceptance rates for Betaseron treatment in …